If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
Four major computed tomography (CT) system manufacturers in the United States recently released new systems in the past year featuring innovative scanner technology to reduce radiation dose, boost image quality and to be mindful of the current conservative economic climate in healthcare. GE, Siemens, Philips and Toshiba all released their next generation CT systems, each offering significant advances over technology these vendors previously offered.
The U.S. ultrasound market reached an all-time high of $1.44 billion in 2013 — a growth of almost 3 percent over 2012, according to Klein Biomedical Consultants’ “The Medical Diagnostic Ultrasound Market in the USA: Challenges & Opportunities in the New Millennium” 2013 report. Areas that contributed to market growth included musculoskeletal ultrasound and point-of-care ultrasound, which saw double-digit growth in 2013. “In spite of the uncertainties caused by the Affordable Care Act, continued declines in reimbursement and slow economic growth, we saw an uptick in ultrasound purchases,” said Harvey Klein, Ph.D., market analyst and author of the report.
Physicians at Northwestern Memorial Hospital in Chicago were as stunned in 1979 by Godfrey Hounsfield’s exclamation as Hounsfield was at the computed tomography (CT) image. “My word, what is that?” asked the inventor of computed tomography, who later that year would receive the Nobel Peace Prize for his invention.
The U.S. magnetic resonance imaging (MRI) market has been stable for the last few years. With an estimated value of $1.25 billion, the market has been flat with very low, if any, growth. It is predominantly a replacement market, with the majority of hospitals and imaging facilities upgrading older systems to newer ones. From a field strength standpoint, 1.5T and 3.0T systems dominate the market — approximately 65 and 35 percent, respectively.
IBA and Philips Healthcare announced the signing of a global collaboration to provide advanced diagnostic and therapeutic solutions for the treatment of cancer.
Angiographic imaging system vendors have developed several new technologies to address emerging cath lab trends, including the need to reduce radiation dose, improve image quality and enable advanced procedural image guidance. All three of these points have become increasingly important as more complex procedures are attempted in interventional cardiology cath labs and hybrid ORs. These procedures include transcatheter aortic valve replacement (TAVR), mitral clip valve repairs, left atrial appendage (LAA) occlusions, atrial and ventricular septal defect closures, and new interventions for both electrophysiology (EP) and heart failure.
Arc-based radiation therapy continues to gain ground as physicians opt for treatment options that not only are more precisely tailored to each tumor site, but also delivered in fewer visits, which is significantly more convenient for both patients and cancer centers. With a variety of radiation therapy techniques available, from intensity-modulated radiation therapy (IMRT) and whole-body irradiation (WBI) to proton therapy and stereotactic body radiation therapy (SBRT), cancer centers around the country are now, more than ever, able to offer patients a more effective solution for targeting and treating their diseases.
Philips has launched Affiniti. The new ultrasound system made its debut at the European Society of Cardiology (ESC) Congress 2014 in Barcelona.
August 27, 2014 — Philips Healthcare announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its precision planning application for transcatheter aortic valve implantation (TAVI) treatments.
August 12, 2014 — Elekta and Philips Healthcare announced The Christie NHS Foundation Trust, a specialist cancer center based in Manchester, England, will join a consortium whose mission is to develop the clinical value of an integrated magnetic resonance imaging (MRI)-guided radiation therapy system. Such a system would, in principle, improve the practice of radiotherapy via real-time visualization of cancer targets.